European medicines regulator brings forward Moderna's vaccine review date

Europe's medicines regulator on Thursday set up an exceptional meeting for Jan. 6 to assess the marketing authorisation application for Moderna's COVID-19 vaccine.

EMA had earlier planned to meet on Jan. 12 to review the application.

Also Read: Health News Roundup: Doses under COVAX scheme; Moderna CEO on production target for 2021 and more